Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,325,577
  • Shares Outstanding, K 313,420
  • Annual Sales, $ 2,794 M
  • Annual Income, $ -116,890 K
  • EBIT $ 360 M
  • EBITDA $ 626 M
  • 60-Month Beta 1.05
  • Price/Sales 0.82
  • Price/Cash Flow 5.27
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 45.24% ( -7.25%)
  • Historical Volatility 32.45%
  • IV Percentile 9%
  • IV Rank 18.59%
  • IV High 196.37% on 06/21/24
  • IV Low 10.73% on 10/11/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 29
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 10,348
  • Open Int (30-Day) 11,083

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.16
  • Number of Estimates 2
  • High Estimate 0.16
  • Low Estimate 0.15
  • Prior Year 0.15
  • Growth Rate Est. (year over year) +6.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.02 +4.56%
on 05/23/25
8.01 -8.36%
on 05/05/25
-0.63 (-7.90%)
since 05/02/25
3-Month
6.68 +9.88%
on 04/10/25
9.10 -19.34%
on 03/13/25
-1.42 (-16.21%)
since 03/03/25
52-Week
6.29 +16.69%
on 06/28/24
9.48 -22.53%
on 11/12/24
+0.73 (+11.04%)
since 06/03/24

Most Recent Stories

More News
Amneal to Participate at Upcoming Investor Conferences in June

AMRX : 7.36 (-0.81%)
Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults

AMRX : 7.36 (-0.81%)
Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals Stock?

Investors in Amneal Pharmaceuticals, Inc. AMRX need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $2.5 Call had some of the highest implied...

AMRX : 7.36 (-0.81%)
Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals Stock?

Investors in Amneal Pharmaceuticals, Inc. AMRX need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $2.5 Call had some of the highest implied...

AMRX : 7.36 (-0.81%)
Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S.

AMRX : 7.36 (-0.81%)
3 Value Stocks in Hot Water

3 Value Stocks in Hot Water

HLF : 7.57 (-1.69%)
DNB : 9.02 (unch)
AMRX : 7.36 (-0.81%)
3 Small-Cap Stocks Facing Headwinds

3 Small-Cap Stocks Facing Headwinds

SCS : 10.43 (+2.46%)
HAYW : 13.87 (+0.80%)
AMRX : 7.36 (-0.81%)
Amneal: Q1 Earnings Snapshot

Amneal: Q1 Earnings Snapshot

AMRX : 7.36 (-0.81%)
Buy, Sell or Hold JAZZ Stock? Key Tips Ahead of Q1 Earnings

Jazz Pharmaceuticals JAZZ is set to report first-quarter 2025 earnings on May 6, after market close. The Zacks Consensus Estimate for the quarter’s sales and earnings is pegged at $978.6 million and...

JAZZ : 109.18 (+0.82%)
AMRX : 7.36 (-0.81%)
3 Profitable Stocks Skating on Thin Ice

3 Profitable Stocks Skating on Thin Ice

TMO : 397.53 (+0.27%)
AMRX : 7.36 (-0.81%)
KTOS : 38.95 (+2.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

3rd Resistance Point 7.66
2nd Resistance Point 7.55
1st Resistance Point 7.48
Last Price 7.36
1st Support Level 7.31
2nd Support Level 7.20
3rd Support Level 7.13

See More

52-Week High 9.48
Fibonacci 61.8% 8.26
Fibonacci 50% 7.88
Fibonacci 38.2% 7.51
Last Price 7.36
52-Week Low 6.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
OSZAR »